Flisiak, R.; Antonov, K.; Drastich, P.; Jarcuska, P.; Maevskaya, M.; Makara, M.; Puljiz, Ž.; Štabuc, B.; Trifan, A.
Practice Guidelines of the Central European Hepatologic Collaboration (CEHC) on the Use of Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease Undergoing Invasive Procedures. J. Clin. Med. 2021, 10, 5419.
https://doi.org/10.3390/jcm10225419
AMA Style
Flisiak R, Antonov K, Drastich P, Jarcuska P, Maevskaya M, Makara M, Puljiz Ž, Štabuc B, Trifan A.
Practice Guidelines of the Central European Hepatologic Collaboration (CEHC) on the Use of Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease Undergoing Invasive Procedures. Journal of Clinical Medicine. 2021; 10(22):5419.
https://doi.org/10.3390/jcm10225419
Chicago/Turabian Style
Flisiak, Robert, Krasimir Antonov, Pavel Drastich, Peter Jarcuska, Marina Maevskaya, Mihály Makara, Željko Puljiz, Borut Štabuc, and Anca Trifan.
2021. "Practice Guidelines of the Central European Hepatologic Collaboration (CEHC) on the Use of Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease Undergoing Invasive Procedures" Journal of Clinical Medicine 10, no. 22: 5419.
https://doi.org/10.3390/jcm10225419
APA Style
Flisiak, R., Antonov, K., Drastich, P., Jarcuska, P., Maevskaya, M., Makara, M., Puljiz, Ž., Štabuc, B., & Trifan, A.
(2021). Practice Guidelines of the Central European Hepatologic Collaboration (CEHC) on the Use of Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease Undergoing Invasive Procedures. Journal of Clinical Medicine, 10(22), 5419.
https://doi.org/10.3390/jcm10225419
